These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 29335525)

  • 1. Urothelial cancer: Optimizing and integrating cisplatin-based chemotherapy across the disease spectrum.
    Raman JD
    Nat Rev Urol; 2018 Mar; 15(3):139-140. PubMed ID: 29335525
    [No Abstract]   [Full Text] [Related]  

  • 2. The Efficacy of Postoperative Adjuvant Chemotherapy for Patients with pT3N0M0 Upper Tract Urothelial Carcinoma.
    Huang YC; Chen MF; Shi CS; Shindel AW; Huang CE; Pang ST; Chuang CK; Chen CS; Chang YH; Lin WY; Ho DR; Chin CC; Kuo YH; Wu CF
    J Urol; 2015 Aug; 194(2):323-9. PubMed ID: 25796114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High Response Rates to Neoadjuvant Chemotherapy in High-Grade Upper Tract Urothelial Carcinoma.
    Meng X; Chao B; Vijay V; Silver H; Margolin EJ; Balar A; Taneja SS; Shah O; Bjurlin MA; Anderson CB; Huang WC
    Urology; 2019 Jul; 129():146-152. PubMed ID: 30930207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of post-nephroureterectomy cisplatin-based adjuvant chemotherapy for locally advanced upper tract urothelial carcinoma: a multi-institutional retrospective study.
    Nakagawa T; Komemushi Y; Kawai T; Otsuka M; Miyakawa J; Uemura Y; Kanatani A; Taguchi S; Naito A; Suzuki M; Nishimatsu H; Hirano Y; Tanaka Y; Matsumoto A; Miyazaki H; Fujimura T; Fukuhara H; Kume H; Igawa Y; Homma Y
    World J Urol; 2017 Oct; 35(10):1569-1575. PubMed ID: 28397000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of adjuvant chemotherapy for lymph node-positive upper tract urothelial carcinoma and the prognostic significance of C-reactive protein: A multi-institutional, retrospective study.
    Fujita K; Inamoto T; Yamamoto Y; Tanigawa G; Nakayama M; Mori N; Tsujihata M; Azuma H; Nonomura N; Uemura M
    Int J Urol; 2015 Nov; 22(11):1006-12. PubMed ID: 26153093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Upper Tract Urothelial Carcinomas: Prognostic Factors and Outcomes in Patients With Non-Lymph Node Distant Metastasis.
    Sevillano E; Werner L; Bossé D; Lalani AA; Wankowicz SAM; de Velasco G; Farina M; Lundgren K; Choueiri TK; González Del Alba A; Bellmunt J
    Clin Genitourin Cancer; 2017 Dec; 15(6):e1089-e1094. PubMed ID: 28864222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. UTUC in 2017: Emerging evidence on treating upper tract urothelial cancer.
    Grande P; Rouprêt M
    Nat Rev Urol; 2018 Feb; 15(2):73-74. PubMed ID: 29182602
    [No Abstract]   [Full Text] [Related]  

  • 8. Surgical consolidation of initially unresectable urothelial carcinoma: an incremental opportunity to cure.
    Siefker-Radtke AO
    Expert Rev Anticancer Ther; 2009 Dec; 9(12):1701-3. PubMed ID: 19954279
    [No Abstract]   [Full Text] [Related]  

  • 9. Renal safety and efficacy of cisplatin-based chemotherapy in patients with a solitary kidney after nephroureterectomy for urothelial carcinoma of the upper urinary tract.
    Cho KS; Joung JY; Seo HK; Cho IC; Chung HS; Chung J; Lee KH
    Cancer Chemother Pharmacol; 2011 Apr; 67(4):769-74. PubMed ID: 20532510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Are the Formulas Used to Estimate Renal Function Adequate for Patients Treated With Cisplatin-Based Chemotherapy After Nephroureterectomy for Upper Tract Urothelial Carcinoma?
    Niwa N; Kikuchi E; Masashi M; Tanaka N; Nishiyama T; Miyajima A; Saito S; Oya M
    Clin Genitourin Cancer; 2016 Oct; 14(5):e501-e507. PubMed ID: 27236770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advancements in the clinical management of upper tract urothelial carcinoma.
    Taylor J; Meng X; Ghandour R; Margulis V
    Expert Rev Anticancer Ther; 2019 Dec; 19(12):1051-1060. PubMed ID: 31770492
    [No Abstract]   [Full Text] [Related]  

  • 12. The effect of contralateral kidney volume on renal function after radical nephroureterectomy: Implications for eligibility for neoadjuvant chemotherapy for upper tract urothelial cancer.
    Song W; Sung HH; Han DH; Jeong BC; Seo SI; Jeon SS; Lee HM; Choi HY; Jeon HG
    Urol Oncol; 2017 Mar; 35(3):114.e1-114.e7. PubMed ID: 27908680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical response to induction chemotherapy predicts improved survival outcome in urothelial carcinoma with clinical lymph nodal metastasis treated by consolidative surgery.
    Urakami S; Yuasa T; Yamamoto S; Sakura M; Tanaka H; Hayashi T; Uehara S; Inoue Y; Fujii Y; Masuda H; Fukui I; Yonese J
    Int J Clin Oncol; 2015 Dec; 20(6):1171-8. PubMed ID: 25953680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical studies of chemotherapy for patients with a solitary kidney after nephroureterectomy for advanced upper urothelial transitional cell carcinoma].
    Tsujimura A; Takayama H; Tsukikawa M; Imazu T; Sugao H; Takaha M
    Hinyokika Kiyo; 1995 Mar; 41(3):183-9. PubMed ID: 7741070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunotherapy for Urothelial Carcinoma: Current Evidence and Future Directions.
    Tripathi A; Plimack ER
    Curr Urol Rep; 2018 Nov; 19(12):109. PubMed ID: 30406502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intracavitary therapies for upper tract urothelial carcinoma.
    Knoedler JJ; Raman JD
    Expert Rev Clin Pharmacol; 2018 May; 11(5):487-493. PubMed ID: 29634361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of neoadjuvant chemotherapy on locally advanced upper tract urothelial carcinoma: A systematic review and meta-analysis.
    Kim DK; Lee JY; Kim JW; Hah YS; Cho KS
    Crit Rev Oncol Hematol; 2019 Mar; 135():59-65. PubMed ID: 30819447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neoadjuvant and adjuvant chemotherapy use in upper tract urothelial carcinoma.
    Cohen A; Kuchta K; Park S
    Urol Oncol; 2017 Jun; 35(6):322-327. PubMed ID: 28065502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjuvant Therapy in Muscle-Invasive Bladder Cancer and Upper Tract Urothelial Carcinoma.
    Achkar T; Parikh RA
    Urol Clin North Am; 2018 May; 45(2):257-266. PubMed ID: 29650141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of the ASA Physical Status Score on Adjuvant Chemotherapy Eligibility and Survival of Upper Tract Urothelial Carcinoma Patients: a Multicenter Study.
    Kang HW; Seo SP; Kim WT; Kim YJ; Yun SJ; Lee SC; Choi YD; Ha YS; Kim TH; Kwon TG; Byun SS; Jeh SU; Kim WJ
    J Korean Med Sci; 2017 Feb; 32(2):335-342. PubMed ID: 28049247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.